Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Cephalalgia : an International Journal of Headache
|
December 23, 2015
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database
Zsolt Hepp, Noah L Rosen, Patrick G Gillard, et al.
Urologic Oncology
|
July 9, 2021
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis
Alicia K Morgans, Zsolt Hepp, Sonali N Shah, et al.
CNS Drugs
|
April 6, 2017
Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
Katelyn R Keyloun, Ryan N Hansen, Zsolt Hepp, et al.
Clinical Epidemiology
|
November 21, 2022
Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology
Brian Bloudek, Heidi S Wirtz, Zsolt Hepp, et al.
Clinical Epidemiology
|
June 27, 2023
Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy-Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling
Matthew D Galsky, Heidi S Wirtz, Brian Bloudek, et al.
Clinical Genitourinary Cancer
|
September 10, 2022
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy
Alicia K Morgans, Simrun Grewal, Zsolt Hepp, et al.
Cephalalgia : an International Journal of Headache
|
November 13, 2016
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp, David W Dodick, Sepideh F Varon, et al.
The American Journal of Managed Care
|
May 25, 2023
Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model
Heidi S Wirtz, Zsolt Hepp, Simrun Grewal, et al.
The Journal of Sexual Medicine
|
August 2, 2017
Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF)
Heather L Gelhorn, Laurie J Roberts, Nikhil Khandelwal, et al.
Urologic Oncology
|
May 19, 2023
Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
Alicia K Morgans, Matthew D Galsky, Phoebe Wright, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Cephalalgia : an International Journal of Headache
|
December 23, 2015
Comparative effectiveness of onabotulinumtoxinA versus oral migraine prophylactic medications on headache-related resource utilization in the management of chronic migraine: Retrospective analysis of a US-based insurance claims database
Zsolt Hepp, Noah L Rosen, Patrick G Gillard, et al.
Urologic Oncology
|
July 9, 2021
Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis
Alicia K Morgans, Zsolt Hepp, Sonali N Shah, et al.
CNS Drugs
|
April 6, 2017
Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD)
Katelyn R Keyloun, Ryan N Hansen, Zsolt Hepp, et al.
Clinical Epidemiology
|
November 21, 2022
Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology
Brian Bloudek, Heidi S Wirtz, Zsolt Hepp, et al.
Clinical Epidemiology
|
June 27, 2023
Benchmarking Maintenance Therapy Survival in First-Line Platinum-Based Chemotherapy-Treated Patients with Advanced Urothelial Carcinoma Using Simulated Disease Modeling
Matthew D Galsky, Heidi S Wirtz, Brian Bloudek, et al.
Clinical Genitourinary Cancer
|
September 10, 2022
Clinical and Patient-Reported Outcomes of Advanced Urothelial Carcinoma Following Discontinuation of PD-1/L1 Inhibitor Therapy
Alicia K Morgans, Simrun Grewal, Zsolt Hepp, et al.
Cephalalgia : an International Journal of Headache
|
November 13, 2016
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp, David W Dodick, Sepideh F Varon, et al.
The American Journal of Managed Care
|
May 25, 2023
Health care resource utilization, quality metrics, and costs of bladder cancer within the Oncology Care Model
Heidi S Wirtz, Zsolt Hepp, Simrun Grewal, et al.
The Journal of Sexual Medicine
|
August 2, 2017
Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF)
Heather L Gelhorn, Laurie J Roberts, Nikhil Khandelwal, et al.
Urologic Oncology
|
May 19, 2023
Real-world treatment patterns and clinical outcomes with first-line therapy in patients with locally advanced/metastatic urothelial carcinoma by cisplatin-eligibility
Alicia K Morgans, Matthew D Galsky, Phoebe Wright, et al.
Page
of 4